Pelin Korkmaz – InmunoES

IL-5/IL-5R blockade enables safe non-steroidal anti-inflammatory agent reintroduction in non-steroidal anti-inflammatory exacerbated respiratory disease

3 de September de 2026 by Pelin Korkmaz

BackgroundBiologic therapies targeting the interleukin-5 (IL-5) pathway improve asthma control and chronic rhinosinusitis with nasal polyposis (CRSwNP) in patients with non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (NERD)…

Tuberculosis screening in adult patients with inborn errors of immunity: a single-center cohort study

24 de July de 2026 by Pelin Korkmaz

BackgroundData on tuberculosis, a leading cause of infectious disease mortality, in patients with inborn errors of immunity (IEI) are limited.ObjectiveThis study aimed to evaluate the burden of tuberculosis and the diagnostic utility of the tuberculin …